Vitruvean is a Contract Research Organization (CRO) which utilizes a Drosophila-based
drug discovery screening platform as a unique approach towards identifying mechanisms
and compounds for treatment of neurodegenerative diseases. We have incorporated
an arsenal of robotics and automation in conjunction with carefully characterized
models of CNS disorders creating a medium-throughput, behavioral screening paradigm
that is unmatched in the biotechnology industry. Vitruvean is working with JSW
Life Sciences, a leader in neuroscience research and drug development, as their
marketing partner.